pharmaphorum
MARCH 19, 2021
His vision is to transform the way businesses operate by helping them increase speed to market while also improving patient care. She is founder and host of the podcast and television segment “Human Condition MD” She graduated from George Washington University School Of Medicine in 2010. and Israel.
IDStewardship
MARCH 23, 2023
Laboratorians, clinicians, and other healthcare professionals engaged to discuss the importance of essential tools for rapid diagnostics and stewardship data for effective patient care to help save lives—particularly when dealing with drug-resistant infections. You can find him on Twitter @Brian_Raux.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 23, 2021
“At the end of the day, I think technological integration will be key and we want to find that sweet spot between the clinician’s time, optimizing patient care, and ultimately providing the best patient care,” she said. She graduated from George Washington University School Of Medicine in 2010. and Israel.
pharmaphorum
JANUARY 7, 2022
I often ask myself where the next leap in patient care will come from. In my opinion, one crucial area that stands out is better understanding patient perspectives and experiences through patient-reported outcome measures (PROMs). Despite this, many studies do not make use of PROMs, or lack qualitative patient input.
pharmaphorum
SEPTEMBER 9, 2021
of GDP between 2010 and 2017, and this gap will continue to accumulate over time “creating an ever-growing wedge”, according to the report. “If Generics and biosimilars are less expensive for patients and healthcare systems, but sustainable access to modern medicine is inconsistent across CEE countries.
European Pharmaceutical Review
SEPTEMBER 14, 2023
EMA prepares for winter antibiotic shortages That slowdown resulted in 211 drug shortages in 2010—the highest number recorded in a single year at the time. By the time biotechs were ready to invest and ramp back up, ingredients and manufacturing capacity were scarce.
pharmaphorum
SEPTEMBER 8, 2020
Governments do not have to look hard to find ample opportunity for their health systems to accelerate biosimilar adoption practices and drive huge healthcare savings while still delivering excellent high quality patient care, as noted openly by the FDA during the last 18 months. Unpleasant truth: let’s embrace it and take action.
Expert insights. Personalized for you.
141 
Let's personalize your content